A2 Biotherapeutics develops T cell therapies targeting solid tumors precisely.
A2 Biotherapeutics has raised $300K in total funding. The most recent round was Grant. The last funding was announced in May 2025.
A2 Biotherapeutics's investors include Samsara BioCapital, The Column Group, Vida Ventures, Casdin Capital, Nextech Invest.
A2 Biotherapeutics is headquartered in Agoura Hills, United States.
A2 Biotherapeutics develops T cell therapies targeting solid tumors precisely.
A2 Biotherapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"A2 Biotherapeutics — Funding & Investors." VCBacked, May 6, 2025, https://www.vcbacked.co/company/a2-biotherapeutics. Accessed November 11, 2026.
VCBacked. (2025). A2 Biotherapeutics — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/a2-biotherapeutics
{{cite web |title=A2 Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/a2-biotherapeutics |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at A2 Biotherapeutics? Request a listing update